Skip to main content
. 2016 Apr 11;50(3):173–180. doi: 10.4132/jptm.2016.02.02

Table 2.

Example of pathologic report form in breast cancer after neoadjuvant therapy

Pathologic report form
Gross finding
 Residual identified tumor: yes/no
 Quadrant of tumor
 Multifocality: yes/no
 Size of residual tumor: xx mm
 Identified clip of marker: yes/no
Microscopic finding
 Histologic diagnosis: invasive carcinoma, NST
 Histologic grade: I/II/III (tubule score–nuclear grade–mitosis score)
 Size of residual tumor bed: x mm
 Size of the largest residual invasive carcinoma: x mm
 Residual tumor cellularity: %
 Lymphovascular invasion: absent/present
 DCIS component: yes/no
  Total tumor size including DCIS: x mm
  Extensive intraductal component: yes/no
  Type: cribriform/micropapillary/solid/papillary
  Nuclear grade: low/intermediate/high
  Necrosis: absent/present (focal/commedo)
 ER/PR/HER-2 status: optional
Resection margin
 Invasive carcinoma: absent/present; distance to the closest margin
 DCIS: absent/present; distance to the closest margin
 Tumor bed: absent/present
Lymph node status
 Number of sentinel lymph nodes
 Number of total axillary lymph nodes
 Number of lymph nodes with macrometastasis
  Size of largest metastasis: mm
 Number of lymph nodes with micrometastasis
 Number of lymph nodes with isolated tumor cells
 Number of lymph nodes with histologic evidence of treatment response but no tumor cells
 Extracapsular extension: yes/no

NST, no specific type; DCIS, ductal carcinoma in situ; ER, estrogen receptor; PR, progesterone receptor; HER-2, human epidermal growth factor receptor-2.